Literature DB >> 15148991

Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease.

J W Ironside1, M W Head.   

Abstract

The neuropathological features of human prion diseases are spongiform change, neuronal loss, astrocytic proliferation and the accumulation of PrP(Sc), the abnormal isoform of prion protein (PrP). The pattern of brain involvement is remarkably variable and is substantially influenced by the host PrP genotype and PrP(Sc) isotype. Variant Creutzfeldt-Jakob disease (vCJD) is a novel human prion disease which results from exposure to the bovine spongiform encephalopathy (BSE) agent. The neuropathology of vCJD shows consistent characteristics, with abundant florid and cluster plaques in the cerebrum and cerebellum, and widespread accumulation of PrP(res) on immunocytochemistry. These features are distinct from all other types of human prion disease. Spongiform change is most marked in the basal ganglia, while the thalamus exhibits severe neuronal loss and gliosis in the posterior nuclei. These areas of thalamic pathology correlate with the areas of high signal seen in the thalamus on magnetic resonance imaging (MRI) examination of the brain. Western blot analysis of PrP(Sc) in the brain in vCJD tissue shows a uniform isotype, with a glycoform ratio characterized by predominance of the diglycosylated band, distinct from sporadic CJD. PrP(Sc) accumulation in vCJD is readily detectable outside the brain, in contrast with other forms of human prion disease, particularly in the lymphoid system and in parts of the peripheral nervous system. This has raised concern about the possible iatrogenic transmission of vCJD by contaminated surgical instruments, or blood. All cases of vCJD are methionine homozygotes at codon 129 of the prion protein gene (PRNP). Continued surveillance is required to investigate cases of vCJD in the UK and other countries where BSE has been reported, particularly as cases of 'human BSE' in individuals who are MV or VV at codon 129 of the PrP gene have not yet been identified. Histological, genetic and biochemical techniques are essential tools for the adequate diagnosis and investigation of human prion diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148991     DOI: 10.1007/978-3-662-08441-0_6

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  19 in total

Review 1.  Neuropathological investigation of dementia: a guide for neurologists.

Authors:  S Love
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

2.  A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease.

Authors:  Clive Hamlin; Gianfranco Puoti; Sally Berri; Elliott Sting; Carrie Harris; Mark Cohen; Charles Spear; Alberto Bizzi; Sara M Debanne; Douglas Y Rowland
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

3.  Therapeutic effect of CHF5074, a new γ-secretase modulator, in a mouse model of scrapie.

Authors:  Giorgio Poli; Erica Corda; Barbara Lucchini; Maria Puricelli; Piera Anna Martino; Paola Dall'ara; Gino Villetti; Silvio R Bareggi; Cristiano Corona; Elena Vallino Costassa; Paola Gazzuola; Barbara Iulini; Maria Mazza; Pierluigi Acutis; Paolo Mantegazza; Cristina Casalone; Bruno P Imbimbo
Journal:  Prion       Date:  2012 Jan-Mar       Impact factor: 3.931

4.  Classification of sporadic Creutzfeldt-Jakob disease based on clinical and neuropathological characteristics.

Authors:  José Cortiñas Abrahantes; Marc Aerts; Bart van Everbroeck; Claude Saegerman; Dirk Berkvens; Helena Geys; Koen Mintiens; Stefan Roels; Patrick Cras
Journal:  Eur J Epidemiol       Date:  2007-06-21       Impact factor: 8.082

5.  Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice.

Authors:  Jonathan D F Wadsworth; Susan Joiner; Jacqueline M Linehan; Melanie Desbruslais; Katie Fox; Sharon Cooper; Sabrina Cronier; Emmanuel A Asante; Simon Mead; Sebastian Brandner; Andrew F Hill; John Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-03       Impact factor: 11.205

6.  Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions.

Authors:  Joaquín Castilla; Dennisse Gonzalez-Romero; Paula Saá; Rodrigo Morales; Jorge De Castro; Claudio Soto
Journal:  Cell       Date:  2008-09-05       Impact factor: 41.582

7.  The molecular epidemiology of variant CJD.

Authors:  Graham A Mackay; Richard Sg Knight; James W Ironside
Journal:  Int J Mol Epidemiol Genet       Date:  2011-06-03

Review 8.  The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease.

Authors:  Heather H C Lau; Martin Ingelsson; Joel C Watts
Journal:  Acta Neuropathol       Date:  2020-08-02       Impact factor: 17.088

9.  Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases.

Authors:  A M Isaacs; C Powell; T E Webb; J M Linehan; J Collinge; S Brandner
Journal:  Neuropathol Appl Neurobiol       Date:  2008-08       Impact factor: 8.090

10.  Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States.

Authors:  Silvio Notari; Francisco J Moleres; Stephen B Hunter; Ermias D Belay; Lawrence B Schonberger; Ignazio Cali; Piero Parchi; Wun-Ju Shieh; Paul Brown; Sherif Zaki; Wen-Quan Zou; Pierluigi Gambetti
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.